TY - JOUR
T1 - GuitarPD
T2 - A Randomized Pilot Study on the Impact of Nontraditional Guitar Instruction on Functional Movement and Well-Being in Parkinson's Disease
AU - Bastepe-Gray, Serap
AU - Wainwright, Lavinia
AU - Lanham, Diane C.
AU - Gomez, Gabriela
AU - Kim, Jieung S.
AU - Forshee, Zane
AU - Kaas, Bonnie
AU - McCoy, Arita
AU - McGregor, Colin
AU - Moukheiber, Emile
AU - Rajan, Suraj
AU - Suarez-Cedeno, Gerson
AU - Wang, Jiangxia
AU - Brennan, Sean
AU - Coughlin, Shane
AU - Kang, Kyurim
AU - Pantelyat, Alexander
N1 - Publisher Copyright:
© 2022 Serap Bastepe-Gray et al.
PY - 2022
Y1 - 2022
N2 - Playing musical instruments may have positive effects on motor, emotional, and cognitive deficits in patients with Parkinson's disease (PD). This pilot study examined the feasibility of a six-week nontraditional guitar instruction program for individuals with PD. Twenty-six participants with idiopathic PD (Age: 67.22 ± 8.07; 17 males) were randomly assigned to two groups (intervention first or 6 weeks of usual care control exposure) with stepwise exposure to the guitar intervention condition with cross-over at six weeks. Outcomes were assessed at baseline, 6, 12, and 18 weeks. Twenty-four participants completed the study. Combined analysis of the groups showed significant BDI-II improvement immediately after intervention completion (3.04 points, 95% CI [-5.2,-0.9], p=0.04). PDQ-39 total quality of life scores improved from baseline to immediately postintervention 5.19 points (95% CI [-9.4,-1.0]) at trend significance (corrected p=0.07). For Group 1 (exposed to the intervention first), MDS-UPDRS total scores improved by a mean of 8.04 points (95% CI [-12.4,-3.7], p=0.004) and remained improved at 12 weeks by 10.37 points (95% CI [-14.7,-6.0], p<0.001). This group also had significant improvements in mood and depression at weeks 6 and 12, remaining significant at week 18 (BDI-II: 3.75, 95% CI [-5.8,-1.7], p=0.004; NeuroQoL-depression: 10.6, 95% CI [-4.9.-1.4], p=0.004), and in anxiety at week 6 and week 18 (NeuroQoL; 4.42, 95% CI [-6.8,-2.1], p=0.004; 3.58, 95% CI [-5.9,-1.2], p=0.02, respectively). We found clinically and statistically significant improvements in mood/anxiety after 6 weeks of group guitar classes in individuals with PD. Group guitar classes can be a feasible intervention in PD and may improve mood, anxiety, and quality of life.
AB - Playing musical instruments may have positive effects on motor, emotional, and cognitive deficits in patients with Parkinson's disease (PD). This pilot study examined the feasibility of a six-week nontraditional guitar instruction program for individuals with PD. Twenty-six participants with idiopathic PD (Age: 67.22 ± 8.07; 17 males) were randomly assigned to two groups (intervention first or 6 weeks of usual care control exposure) with stepwise exposure to the guitar intervention condition with cross-over at six weeks. Outcomes were assessed at baseline, 6, 12, and 18 weeks. Twenty-four participants completed the study. Combined analysis of the groups showed significant BDI-II improvement immediately after intervention completion (3.04 points, 95% CI [-5.2,-0.9], p=0.04). PDQ-39 total quality of life scores improved from baseline to immediately postintervention 5.19 points (95% CI [-9.4,-1.0]) at trend significance (corrected p=0.07). For Group 1 (exposed to the intervention first), MDS-UPDRS total scores improved by a mean of 8.04 points (95% CI [-12.4,-3.7], p=0.004) and remained improved at 12 weeks by 10.37 points (95% CI [-14.7,-6.0], p<0.001). This group also had significant improvements in mood and depression at weeks 6 and 12, remaining significant at week 18 (BDI-II: 3.75, 95% CI [-5.8,-1.7], p=0.004; NeuroQoL-depression: 10.6, 95% CI [-4.9.-1.4], p=0.004), and in anxiety at week 6 and week 18 (NeuroQoL; 4.42, 95% CI [-6.8,-2.1], p=0.004; 3.58, 95% CI [-5.9,-1.2], p=0.02, respectively). We found clinically and statistically significant improvements in mood/anxiety after 6 weeks of group guitar classes in individuals with PD. Group guitar classes can be a feasible intervention in PD and may improve mood, anxiety, and quality of life.
UR - http://www.scopus.com/inward/record.url?scp=85145804164&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85145804164&partnerID=8YFLogxK
U2 - 10.1155/2022/1061045
DO - 10.1155/2022/1061045
M3 - Article
C2 - 35795456
AN - SCOPUS:85145804164
SN - 2090-8083
VL - 2022
JO - Parkinson's Disease
JF - Parkinson's Disease
M1 - 1061045
ER -